Author: Publisher: World Health Organization
ISBN: 9240019103
Category : Medical
Languages : en
Pages : 380
Book Description
The selection and use of essential in vitro diagnostics
Author: Publisher: World Health Organization
ISBN: 9240019103
Category : Medical
Languages : en
Pages : 380
Book Description
Selection and Use of Essential in Vitro Diagnostics: Report of the Third Meeting of the WHO Strategic Advisory Group of Experts on In Vitro Diagnostics, 2020 (including the Third WHO Model List of Essential in Vitro Diagnostics).
Author: The selection and use of essential in vitro diagnostics
Author: World Health OrganizationPublisher: World Health Organization
ISBN: 9240081097
Category : Medical
Languages : en
Pages : 237
Book Description
Technical report of the fourth meeting of the WHO Strategic Advisory Group of Experts on In Vitro Diagnostics, 2022 (including the fourth WHO model list of essential in vitro diagnostics (EDL 4)). This report also includes the applications received for the EDL 4 and a summary of the deliberations and recommendations by the SAGE IVD members and the methodologist that assessed the supportive evidence for the EDL 4 applications.
Executive Summary
Author: World Health Organization. Strategic Advisory Group on In Vitro Diagnostics. MeetingPublisher:
ISBN:
Category :
Languages : en
Pages : 34
Book Description
"Access to good quality, affordable, and appropriate health products is indispensable to advance universal health coverage,address health emergencies,and promote healthier populations–the three strategic priorities of the World Health Organization (WHO)Thirteenth General Programme of Work 2019–2023.1Without access to In vitrodiagnostics (IVDs),health providers cannot diagnose patients effectively and promptly or provide appropriate treatments.In March 2017, the WHO Expert Committee on Selection and Use of Essential Medicines recommended the development of a Model List of Essential In Vitro Diagnostics (EDL), to complement the WHO Model List of Essential Medicines (EML). To support the EDL and to advise on other in vitro diagnostic initiatives, WHO created a Strategic Advisory Group of Experts on In VitroDiagnostics (SAGE-IVD). The SAGE-IVD, which includes 19 multidisciplinary members with global representation, held its first meeting from 16–20April 2018 at WHO headquarters, Geneva. The SAGE IVD made recommendations for the content, format and implementation of the first edition of the EDL.It is foreseen that EDL will be an important tool in increasing access to appropriate, affordable and quality-assured IVDs, particularly where they are most needed to address health priorities"--Executive summary.
Selection and Use of Essential in Vitro Diagnostics: Report of the Second Meeting of the WHO Strategic Advisory Group of Experts on In Vitro Diagnostics, 2019 (including the Second WHO Model List of Essential in Vitro Diagnostics).
Author: world health organizationPublisher:
ISBN:
Category :
Languages : en
Pages : 0
Book Description
The selection and use of essential in vitro diagnostics
Author: World Health OrganizationPublisher: World Health Organization
ISBN: 9241210311
Category : Medical
Languages : en
Pages : 236
Book Description
The report of the second meeting of the Strategic Advisory Group of Experts on In Vitro was launched in November 2019 and includes the updated WHO Model List of Essential In Vitro Diagnostics (EDL), which lists 122 in vitro diagnostic categories and incorporates evidence base and expositions of the applications to be included on the EDL and the basis of decisions made to list or reject these IVDs. The evidence is expected to guide countries on constituting their national EDLs. In addition the report also presents decision summaries on suggested edits to the first EDL, recommendations on various matters of in vitro diagnostics including the framework for developing future editions, and proposed actions for implementation of the EDL in regions and countries.
Selection of essential in vitro diagnostics at country level using the WHO Model List of Essential In Vitro Diagnostics to develop and update a national list of essential in vitro diagnostics
Author: Publisher: World Health Organization
ISBN: 9240030921
Category : Medical
Languages : en
Pages : 64
Book Description
The selection and use of essential medicines
Author: Publisher: World Health Organization
ISBN: 9240041133
Category : Medical
Languages : en
Pages : 881
Book Description
The 23rd meeting of the WHO Expert Committee on Selection and Use of Essential Medicines was coordinated from Geneva, Switzerland, and held virtually from 21 June to 2 July 2021. The Committee considered 88 applications proposing additions, changes and deletions of medicines, medicine classes and formulation on the Model Lists of Essential Medicines. The Committee evaluated the scientific evidence for comparative effectiveness, safety and cost-effectiveness of the medicines in question. The Committee also considered a review of the therapeutic alternatives for medicines on the Model Lists, and update to the AWaRe classification of antibiotics, and reviews and reports relevant to the selection and use of essential medicines.
The WHO AWaRe (Access, Watch, Reserve) antibiotic book
Author: World Health OrganizationPublisher: World Health Organization
ISBN: 9240062386
Category : Medical
Languages : en
Pages : 697
Book Description
WHO implementation handbook for national action plans on antimicrobial resistance
Author: Publisher: World Health Organization
ISBN: 9240041982
Category : Medical
Languages : en
Pages : 80
Book Description
In 2015 the World Health Assembly endorsed the Global action plan on antimicrobial resistance calling on countries to develop and implement national action plans on antimicrobial resistance (AMR). For most countries, the greatest challenge is not developing a national action plan; rather, it is the implementation of the plan based on evidence-based prioritization of activities, systematic monitoring of progress, and ensuring sustainability of efforts. The purpose of this publication is to to provide a practical, stepwise approach to the implementation of the national action plan on AMR within the human health sector; and to provide a process and collation of existing WHO tools to prioritize, cost, implement, monitor and evaluate national action plan activities. The target audience of the publication are national/subnational stakeholders working on AMR within the human health sector. This includes national health authorities, national multisectoral coordination groups, senior technical experts and policymakers involved in implementing AMR activities at all levels of the health system, and implementation partners to accelerate sustainable implementation and monitoring and evaluation of national action plans on AMR.